In the current research study, zinc oxide nanoparticles (ZnO-NPs) were synthesized via a green synthesis technique using the seed extract of Citrullus lanatus. The study further intended to evaluate the potential synergistic effects of ZnO-NPs with antibiotics against multidrug resistant (MDR) bacteria. It was observed that C. lanatus seed extracts obtained by n-hexane and methanolic solvents revealed the presence of constituents, such as tannins, flavonoids, and terpenoids. Furthermore, the extract of n-hexane displayed the strongest antibacterial activity against Yersinia species (17 ± 1.2 mm) and Escherichia coli (17 ± 2.6 mm), while the methanolic extract showed the maximum antibacterial activity against E. coli (17 ± 0.8 mm). Additionally, the ZnO-NP synthesis was confirmed by ultraviolet-visible analysis with a characteristic absorption peak at 280 nm. The Fourier transform infrared spectroscopy analysis suggested the absorption peaks in the 500–3800 cm^–1 range, which corresponds to various groups of tertiary alcohol, aldehyde, amine, ester, aromatic compounds, thiol, amine salt, and primary amine. The scanning electron microscopy spectra of ZnO-NPs demonstrated the presence of zero-dimensional spherical particles with well-dispersed character. Moreover, encapsulation with ZnO-NPs improved the antimicrobial activity of antibiotics against the panel of MDR bacteria, and the increases in the effectiveness of particular antibiotics against MDR bacteria were significant (P = 0.0005). In essence, the synthesized ZnO-NPs have the potential as drug carriers with powerful bactericidal properties that work against MDR bacterial strains. These outcomes are an indication of such significance in pharmaceutical science, giving possibilities for further research and development in this field.

This study isolates oil-degrading bacteria from contaminated soil in automobile workshops, aiming to address environmental pollution from petroleum spills. Nineteen bacterial isolates were screened, with three isolates S4 (Lysinibacillus macroides), M8 (Serratia marcescens), and M9 (S. marcescens), showing significant oil degradation potency. In shake flask assays, S4 degraded 57.8%, M8 60.2%, and M9 58.1% of oil at a 5% concentration. Molecular identification through 16S rRNA gene sequencing confirmed these strains. Plate assays also supported the degradation potential, with growth zones of 38.4 ± 1.3 mm (S4), 39.7 ± 1.9 mm (M8), and 41.2 ± 1.7 mm (M9). Gas chromatography-mass spectrometry analysis of treated oil indicated the presence of hydrocarbons, phenolic compounds, and esters, suggesting microbial interactions, potentially involving the breakdown or transformation of complex hydrocarbons into simpler compounds by bacterial enzymes. These results highlight the potential of these bacterial strains, particularly S4, for the bioremediation of petroleum-contaminated sites.

The aim of the present study is to assess the wastewater treatment efficiency of a low-cost pilot-scale trickling filter (TF) system under a prevailing temperature range of 12 °C–38 °C. Operational data (both influent and effluent) for 330 days were collected from the pilot-scale TF for various physicochemical and biological parameters. Average percentage reductions were observed in the ranges of 52–72, 51–73, 61–81, and 74–89% for BOD₅, COD, TDS, and TSS, respectively, for the whole year except the winter season, where a 74–88% reduction was observed only for TSS, whilst BOD₅, COD, and TDS demonstrated reductions in the ranges of 13–50, 13–49, and 23–61%, respectively. Furthermore, reductions of about 43–55% and 57–86% in fecal coliform count were observed after the 1st and 6th day of treatment, respectively, throughout study period. Moreover, the pilot-scale TF model was based on zero-order kinetics calibrated at 20 °C using experimental BOD₅ data obtained in the month of October to calculate the k₂₀ value, which was further validated to determine the k_t value for each BOD₅ experimental setup. The model resulted in more accurate measurements of the pilot-scale TF and could help to improve its ability to handle different types of wastewater in the future.

Background: Streptococcus mutans is a leading causative agent of dental caries and exerts pathogenicity by forming biofilms. Dental caries continues to be a significant public health issue worldwide, affecting an estimated 2.5 billion people, showing a 14.6% increase over the past decade. Herein, the antibacterial potential of Chlorophyllin extracted from Spinacia oleracea was evaluated against biofilm-forming S. mutans via in vitro and in silico studies. Methodology: The antimicrobial activity of chlorophyllin extract against S. mutans isolates was tested using the agar well diffusion method. Chlorophyllin extract was also tested against biofilm-forming isolates of S. mutans. Chlorophyllin was docked with the antigen I/II (AgI/II) protein of S. mutans to evaluate its antimicrobial mechanism. The chemical structure and canonical SMILES format of Chlorophyllin were obtained from PubChem. Additionally, adsorption, distribution, metabolism, excretion, and toxicity (ADMET) analyses of Chlorophyllin were performed using ADMETlab 2.0 to assess its pharmacokinetic properties. Results: An agar well diffusion assay revealed that all S. mutans isolates were susceptible to Chlorophyllin extract and showed a variety of inhibition zones ranging from 32 to 41 mm. Chlorophyllin reduces the biofilm strength of four isolates from strong to moderate and six from strong to weak. The antibiofilm potential of Chlorophyllin was measured by a reduction in the number of functional groups observed in the Fourier Transform Infrared Spectrometer (FTIR) spectra of the extracellular polymeric substance (EPS) samples. Chlorophyllin showed binding with AgI/II proteins of S. mutans, which are involved in adherence to the tooth surface and initiating biofilm formation. The ADMET analysis revealed that the safety of Chlorophyllin exhibited favorable pharmacokinetic properties. Conclusions: Chlorophyllin stands out as a promising antibacterial and antibiofilm agent against biofilm-forming S. mutans, and its safety profile highlights its potential suitability for further investigation as a therapeutic agent.